Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator ...( CHAPEL HILL N.C. Aug. 10 /- More ...),Health

CHAPEL HILL, N.C., Aug. 10 /PRNewswire/ -- More than 33% of pharmaceutical and biotech companies are able to identify clinical investigators 50% faster than their industry peers. These companies are able to significantly reduce clinical trial costs while improving quality by employing on-going relationship management tactics and centralized databases, according to research probing clinical trial excellence by pharmaceutical consulting firm Best Practices, LLC.

Best Practices LLC's Clinical Trial Excellence Series is a critical tool for executives searching for tactics to optimize their clinical trials. Developed from extensive surveys and interviews with executives at leading pharmaceutical, biotech and clinical research organizations, this series provides a detailed guide to ensuring faster and better clinical trial recruitment and retention.

Profiled in a complimentary download summary at http://www3.best-in-class.com/rr839.htm, research details findings such as:

-- The most valuable services for more than 70% of investigators are

patient recruitment funding and high-quality investigator meetings.

This is in sharp contrast to pharmaceutical and biotech companies

that said investigators most value study coordinator training and

phone support.

-- An adequate and reasonable budget is the most critical factor for

85% of interviewed clinical investigators.

-- The best companies develop and grow customer-relationship databases

with detailed investigator and site information to help jumpstart

study recruitment or entry into a new therapeutic area.

Benchmarked companies, including 3M Pharmaceuticals, Abbott Laboratories, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer and Roche, have succeeded in:

-- Winning 50-80% higher i
'/>"/>

SOURCE Best Practices, LLC Copyright©2007 PR Newswire.

0 GOOD